A
$ Value
$0
Shares
400,000
Price
$0
Filed
May 16
Insider
Name
Vitoc Vlad
Title
Chief Executive Officer
CIK
0001913257
Roles
Director
Officer
10% Owner
Transaction Details
Transaction Date
2025-05-14
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
400,000
Footnotes
The stock options, granted on May 14, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.
Filing Info
Vitoc Vlad's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-10 | MAIA | A | $0 |
| 2025-11-28 | MAIA | ▲ | $57K ★ |
| 2025-11-26 | MAIA | ▲ | $23K |
| 2025-11-25 | MAIA | ▲ | $10K |
| 2025-11-24 | MAIA | ▲ | $10K |
| 2025-11-21 | MAIA | ▲ | $2K |
| 2025-05-14 | MAIA | A | $0 |
Other Insiders at MAIA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CHAOUKI STEVEN M | — | — | 2026-03-31 |
| Smith Stan | — | — | 2026-03-31 |
|
Gryaznov Sergei
Chief Scientific Officer
|
— | — | 2026-04-10 |
| Guerrero Ramiro | — | — | 2026-03-31 |
|
Vitoc Vlad
Chief Executive Officer
|
— | — | 2026-04-10 |
| Louie Ngar Yee | — | — | 2026-03-31 |
| Luput Cristian | — | — | 2026-03-31 |
| Theagene Jean-Manasse | — | — | 2026-03-31 |
|
Himmelreich Jeffrey C
Head of Finance
|
— | — | 2026-04-10 |